Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12612000795897Phase 4Completed
Phase 4, randomised, double-blind trial in acute pain comparing Intranasal ketamine + oral ibuprofen with Intranasal fentanyl + oral ibuprofen (2 arms). Primary endpoint: Mean reduction in pain score at 30 minutes. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12612000795897.